Susan Bobulsky - Net Worth and Insider Trading
Susan Bobulsky Net Worth
The estimated net worth of Susan Bobulsky is at least $3 Million dollars as of 2025-05-03. Susan Bobulsky is the Chief Commercial Officer, MRD of Adaptive Biotechnologies Corp and owns about 347,238 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $3 Million. Details can be seen in Susan Bobulsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan Bobulsky has not made any transactions after 2025-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan Bobulsky
Susan Bobulsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan Bobulsky owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .
Click here to see the complete history of Susan Bobulsky’s form 4 insider trades.
Insider Ownership Summary of Susan Bobulsky
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2025-03-05 | SVP & Diagnostics & clonoSEQ |
Susan Bobulsky Latest Holdings Summary
Susan Bobulsky currently owns a total of 1 stock. Susan Bobulsky owns 347,238 shares of Adaptive Biotechnologies Corp (ADPT) as of March 5, 2025, with a value of $3 Million.
Latest Holdings of Susan Bobulsky
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2025-03-05 | 347,238 | 9.84 | 3,416,822 |
Holding Weightings of Susan Bobulsky
Susan Bobulsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan Bobulsky has made a total of 4 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 26,023 shares on March 5, 2025, which brought Susan Bobulsky around $181,641.
Insider Trading History of Susan Bobulsky
- 1
Susan Bobulsky Trading Performance
Susan Bobulsky Ownership Network
Ownership Network List of Susan Bobulsky
Ownership Network Relation of Susan Bobulsky
Susan Bobulsky Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Susan Bobulsky is the SVP & Diagnostics & clonoSEQ of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Chief Scientific Officer Harlan S Robins , director & CEO and Chairman Chad M Robins , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Susan Bobulsky made 2 insider transaction in Adaptive Biotechnologies Corp (ADPT) with a net sale of 39,014. Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 1,023,797 shares made by Chad M Robins , a net sale of 18,554 shares made by Kyle Piskel , and a net sale of 98,575 shares made by Julie Rubinstein .
In summary, during the past 3 months, insiders sold 1,349,821 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 1,349,821 shares. During the past 18 months, 1,558,638 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,558,638 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Susan Bobulsky Mailing Address
Above is the net worth, insider trading, and ownership report for Susan Bobulsky. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Susan Bobulsky's mailing address is: Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
